Enterobacteriaceae
Neogen® Petrifilm® Enterobacteriaceae Count Plate
Method Description
Enterobacteriaceae Suitability Testing confirms that the Method can effectively detect and recover Enterobacteriaceae in a specific sample matrix. The assessment includes analysis of a fortified sample (matrix spike) and a laboratory control sample (LCS). Recovery from the sample is compared to the LCS to evaluate matrix effects and ensure reliable detection across a broad range of bacterial concentrations.
Analyte List
| Analyte Name | LOD | LOQ | LCL |
|---|---|---|---|
| Enterobacteriaceae (Laboratory Control Sample) | 1.000 CFU/g | 1.000 CFU/g | N/A |
| Enterobacteriaceae (Matrix Spike) | 1.000 CFU/g | 1.000 CFU/g | N/A |
| Enterobacteriaceae (Product Sample) | 1.000 CFU/g | 1.000 CFU/g | N/A |
| Enterobacteriaceae (Method Suitability - Relative Recovery) | N/A | N/A | N/A |
Technical Data Sheet
Additional information
Product-specific suitability per USP <2021> (suitability of the counting method in the presence of the product). Three preparations are analysed side by side: the Product Sample as received, a Matrix Spike (the product inoculated with a low, known level of the target organism, not more than 100 CFU) and a Laboratory Control Sample (the same inoculum in diluent, without product). Relative Recovery (%) = Matrix Spike count ÷ Laboratory Control Sample count, after subtracting any background in the Product Sample. The reportable range 50 – 200% is the USP acceptance criterion (recovery within a factor of two): a result inside the range shows the product neither inhibits nor enhances the method, and routine USP-referenced testing of that product can proceed. Outside the range the method is modified (neutralisers, further dilution or membrane filtration) and the suitability is repeated.
Enterobacteriaceae
See what Cambium analytica can do for your team
contact us
complete this form to connect with a cambium analytica team member
